Table of Contents 

1. Introduction 

1.1 Market Definition & Scope 

1.2 Research Assumptions & Abbreviations 

1.3 Research Methodology 

2. Executive Summary 

 2.1 Market Snapshot 

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035 

 2.3 Market Size & Forecast, By Segmentation, 2022–2035 

  2.3.1 Market Size By Technology 

  2.3.2 Market Size By Product 

  2.3.3 Market Size By Application 

  2.3.4 Market Size By End User 

 2.4 Market Share & Bps Analysis By Region, 2025 

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic 

 2.6 Industry CxO’s Perspective 

3. Market Overview 

 3.1 Market Dynamics 

  3.1.1 Drivers 

  3.1.2 Restraints 

  3.1.3 Opportunities 

  3.1.4 Key Market Trends 

 3.2 Industry PESTLE Analysis 

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth 

 3.4 Industry Supply Chain Analysis 

  3.4.1 Raw Material Suppliers 

  3.4.2 Manufacturers 

  3.4.3 Distributors/Suppliers 

  3.4.4 Customers/End-Users 

 3.5 Industry Life Cycle Assessment 

 3.6 Parent Market Overview 

 3.7 Market Risk Assessment 

4. Statistical Insights & Trends Reporting 

4.1 Molecular Diagnostics Adoption & Testing Metrics

4.1.1 Increasing adoption of molecular diagnostic tests across hospitals, laboratories, and research institutions, with strong demand for infectious disease and cancer testing.

4.1.2 Rising government and private investments in advanced diagnostic technologies to improve early disease detection and healthcare outcomes.

4.1.3 Growing volume of annual molecular tests, including PCR and sequencing-based diagnostics, driven by expanding screening and diagnostic programs.

4.2 Technology Advancements & Innovation Trends

4.2.1 PCR technologies lead the market, followed by rapid growth in next-generation sequencing and other advanced molecular techniques.

4.2.2 Increasing adoption of automated, high-throughput, and point-of-care molecular diagnostic systems for faster and accurate results.

4.2.3 Growing integration of bioinformatics, AI, and digital platforms to enhance data analysis and clinical decision-making.

4.3 Operational & Cost Statistics

4.3.1 Cost of molecular diagnostic testing varies based on technology, with sequencing-based tests generally higher than PCR-based assays.

4.3.2 Significant outsourcing of molecular testing services to specialized diagnostic laboratories due to infrastructure and expertise requirements.

4.3.3 Turnaround time for molecular diagnostic tests is improving with automation, ranging from rapid point-of-care results to longer sequencing workflows.

4.4 Market Dynamics & Industry Trends

4.4.1 Increasing demand driven by rising prevalence of infectious diseases, cancer, and genetic disorders worldwide.

4.4.2 Growing focus on personalized medicine and targeted therapies is accelerating adoption of molecular diagnostics.

4.4.3 Continuous advancements in technology and expanding applications are supporting the long-term growth of the molecular diagnostics market.

5. Molecular Diagnostics Market Segmental Analysis & Forecast, By Technology, 2022 – 2035, Value (USD Billion) 

5.1 Introduction 

 5.2 Polymerase Chain Reaction (PCR)

  5.2.1 Key Trends 

  5.2.2 Market Size & Forecast, 2022 – 2035 

 5.3 Next-Generation Sequencing (NGS)

 5.4 Microarrays 

 5.5 In Situ Hybridization (ISH)

 5.6 Others

6. Molecular Diagnostics Market Segmental Analysis & Forecast, By Product, 2022 – 2035, Value (USD Billion) 

    6.1 Introduction 

 6.2 Reagents & Kits

  6.2.1 Key Trends 

  6.2.2 Market Size & Forecast, 2022 – 2035 

 6.3 Instruments

 6.4 Software & Services

7. Molecular Diagnostics Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion) 

    7.1 Introduction 

 7.2 Infectious Diseases

  7.2.1 Key Trends 

  7.2.2 Market Size & Forecast, 2022 – 2035 

 7.3 Oncology

 7.4 Genetic Testing

 7.5 Blood Screening

 7.6 Others

8. Molecular Diagnostics Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion) 

    8.1 Introduction 

 8.2 Hospitals & Clinics

  8.2.1 Key Trends 

  8.2.2 Market Size & Forecast, 2022 – 2035 

 8.3 Diagnostic Laboratories

 8.4 Research & Academic Institutes

 8.5 Others

9. Molecular Diagnostics Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion) 

9.1 Introduction 

9.2 North America 

 9.2.1 Key Trends 

 9.2.2 Molecular Diagnostics Market Size & Forecast, By Technology, 2022 – 2035 

 9.2.3 Molecular Diagnostics Market Size & Forecast, By Product, 2022 – 2035 

 9.2.4 Molecular Diagnostics Market Size & Forecast, By Application, 2022 – 2035 

 9.2.5 Molecular Diagnostics Market Size & Forecast, By End User, 2022 – 2035 

 9.2.6 Molecular Diagnostics Market Size & Forecast, By Country, 2022 – 2035 

  9.2.6.1 USA 

  9.2.6.2 Canada 

9.3 Europe 

 9.3.1 Key Trends 

 9.3.2 Molecular Diagnostics Market Size & Forecast, By Technology, 2022 – 2035 

 9.3.3 Molecular Diagnostics Market Size & Forecast, By Product, 2022 – 2035 

 9.3.4 Molecular Diagnostics Market Size & Forecast, By Application, 2022 – 2035 

 9.3.5 Molecular Diagnostics Market Size & Forecast, By End User, 2022 – 2035 

 9.3.6 Molecular Diagnostics Market Size & Forecast, By Country, 2022 – 2035 

  9.3.6.1 Germany 

  9.3.6.2 UK 

  9.3.6.3 France 

  9.3.6.4 Italy 

  9.3.6.5 Spain 

  9.3.6.6 Russia 

  9.3.6.7 Poland 

  9.3.6.8 Rest of Europe 

9.4 Asia-Pacific 

 9.4.1 Key Trends 

 9.4.2 Molecular Diagnostics Market Size & Forecast, By Technology, 2022 – 2035 

 9.4.3 Molecular Diagnostics Market Size & Forecast, By Product, 2022 – 2035 

 9.4.4 Molecular Diagnostics Market Size & Forecast, By Application, 2022 – 2035 

 9.4.5 Molecular Diagnostics Market Size & Forecast, By End User, 2022 – 2035 

 9.4.6 Molecular Diagnostics Market Size & Forecast, By Country, 2022 – 2035 

  9.4.6.1 China 

  9.4.6.2 India 

  9.4.6.3 Japan 

  9.4.6.4 South Korea 

  9.4.6.5 Australia 

  9.4.6.6 ASEAN Countries 

  9.4.6.7 Rest of Asia-Pacific 

9.5 Latin America 

 9.5.1 Key Trends 

 9.5.2 Molecular Diagnostics Market Size & Forecast, By Technology, 2022 – 2035 

 9.5.3 Molecular Diagnostics Market Size & Forecast, By Product, 2022 – 2035 

 9.5.4 Molecular Diagnostics Market Size & Forecast, By Application, 2022 – 2035 

 9.5.5 Molecular Diagnostics Market Size & Forecast, By End User, 2022 – 2035 

 9.5.6 Molecular Diagnostics Market Size & Forecast, By Country, 2022 – 2035 

  9.5.6.1 Brazil 

  9.5.6.2 Argentina 

  9.5.6.3 Mexico 

  9.5.6.4 Colombia 

  9.5.6.5 Rest of Latin America 

9.6 Middle East & Africa 

 9.6.1 Key Trends 

 9.6.2 Molecular Diagnostics Market Size & Forecast, By Technology, 2022 – 2035 

 9.6.3 Molecular Diagnostics Market Size & Forecast, By Product, 2022 – 2035 

 9.6.4 Molecular Diagnostics Market Size & Forecast, By Application, 2022 – 2035 

 9.6.5 Molecular Diagnostics Market Size & Forecast, By End User, 2022 – 2035 

 9.6.6 Molecular Diagnostics Market Size & Forecast, By Country, 2022 – 2035 

  9.6.6.1 UAE 

  9.6.6.2 Saudi Arabia 

  9.6.6.3 Qatar 

  9.6.6.4 Egypt 

  9.6.6.5 South Africa 

  9.6.6.6 Rest of Middle East & Africa 

10. Competitive Landscape 

 10.1 Key Players' Positioning 

 10.2 Competitive Developments 

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025 

  10.2.2 Year-Wise Strategies & Development, 2022 – 2025 

  10.2.3 Number Of Strategies Adopted By Key Players, 2025 

 10.3 Market Share Analysis, 2025 

 10.4 Product/Service & Application Benchmarking 

  10.4.1 Product/Service Specifications & Features By Key Players 

  10.4.2 Product/Service Heatmap By Key Players 

  10.4.3 Application Heatmap By Key Players 

 10.5 Industry Start-Up & Innovation Landscape 

10.6 Key Company Profiles 

 10.6.1 Roche Diagnostics

  10.6.1.1 Company Overview & Snapshot 

  10.6.1.2 Product/Service Portfolio 

  10.6.1.3 Key Company Financials 

  10.6.1.4 SWOT Analysis 

 10.6.2 Thermo Fisher Scientific Inc.

 10.6.3 Abbott Laboratories

 10.6.4 Qiagen N.V.

 10.6.5 Danaher Corporation (Cepheid)

 10.6.6 bioMérieux SA

 10.6.7 Siemens Healthineers AG

 10.6.8 Hologic Inc.

 10.6.9 Becton, Dickinson and Company (BD)

 10.6.10 Agilent Technologies Inc.

 10.6.11 Illumina, Inc.

 10.6.12 PerkinElmer, Inc.

 10.6.13 Bio-Rad Laboratories, Inc.

 10.6.14 Sysmex Corporation

 10.6.15 Grifols, S.A.

 10.6.16 Myriad Genetics, Inc.

 10.6.17 Exact Sciences Corporation

 10.6.18 F. Hoffmann-La Roche Ltd.

 10.6.19 GenMark Diagnostics (Roche)

 10.6.20 Tecan Group Ltd.

11. Analyst Recommendations 

 11.1 SNS Insider Opportunity Map 

 11.2 Industry Low-Hanging Fruit Assessment 

 11.3 Market Entry & Growth Strategy 

 11.4 Analyst Viewpoint & Suggestions on Market Growth 

12. Assumptions 

13. Disclaimer 

14. Appendix 

 14.1 List Of Tables 

 14.2 List Of Figures